Cell Free DNA (cfDNA) Testing Global Market Report 2024

Description

Cell-free DNA (cfDNA) testing is a non-invasive diagnostic technique that examines DNA fragments freely circulating in the bloodstream. This testing method is integral to liquid biopsy procedures, enabling the detection and analysis of genetic mutations and alterations without resorting to traditional tissue biopsies.

The primary products within the cell-free DNA (cfDNA) testing market include donor-derived cell-free DNA, circulating cell-free tumor DNA, and cell-free fetal DNA. Donor-derived cell-free DNA originates from transplanted donor organs or tissues and can be found in the recipient's bloodstream. Various platforms are utilized for cfDNA testing, such as next-generation sequencing (NGS), real-time PCR (rPCR) and multiplex PCR, quantitative PCR (qPCR) and digital PCR (dPCR), among others. These platforms are applied across various domains including oncology, non-invasive prenatal testing (NIPT), gynecology, transplantation, and other medical conditions.

The cell-free DNA (cfDNA) testing market research report is one of a series of new reports from The Business Research Company that provides cell-free DNA (cfDNA) testing market statistics, including cell-free DNA (cfDNA) testing industry global market size, regional shares, competitors with a cell-free DNA (cfDNA) testing market share, detailed cell-free DNA (cfDNA) testing market segments, market trends, and opportunities, and any further data you may need to thrive in the cell-free DNA (cfDNA) testing industry. This cell-free DNA (cfDNA) testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell free DNA (cfDNA) testing market size has grown exponentially in recent years. It will grow from $7.07 billion in 2023 to $8.74 billion in 2024 at a compound annual growth rate (CAGR) of 23.6%. The growth during the historic period can be attributed to several factors, including the increased adoption of cfDNA testing in prenatal care, a growing utilization of cfDNA analysis, heightened interest in cfDNA research across various medical fields, and an increase in gaining approvals from regulatory bodies.

The cell free DNA (cfDNA) testing market size is expected to see exponential growth in the next few years. It will grow to $20.63 billion in 2028 at a compound annual growth rate (CAGR) of 23.9%. In the forecast period, growth can be attributed to a shift towards personalized medicine, improvements in healthcare infrastructure, an aging population, and the increasing incidence of cancer. Additionally, the increasing adoption of precision medicine, growing awareness and acceptance of liquid biopsy techniques, and rising investment and funding in cfDNA research are contributing to this growth. Major trends during this period include the adoption of liquid biopsy technologies, advancements in Next-Generation Sequencing (NGS) technology, integration of AI and machine learning in cfDNA testing, development of point-of-care cfDNA tests, and the implementation of cloud-based platforms for data storage and analysis.

The increasing prevalence of cancer is expected to drive the growth of the cell-free DNA (cfDNA) testing market in the future. Cancer encompasses a complex group of diseases characterized by abnormal cell growth and spread in the body. These cells can invade and damage normal tissue, posing significant risks if left unchecked. The rise in cancer prevalence is attributed to factors such as aging populations, lifestyle changes, environmental influences, and advancements in detection and diagnostic methods. cfDNA testing detects genetic mutations linked to cancer at early stages, often before symptoms manifest. This early detection enables timely interventions, enhancing patient outcomes and survival rates by identifying cancer in its initial phases. For example, in February 2024, the World Health Organization (WHO) projected over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Hence, the increasing prevalence of cancer is fueling the growth of the cell-free DNA (cfDNA) testing market.

Key players in the cell-free DNA (cfDNA) testing market prioritize the development of innovative technologies, such as liquid biopsy tests that offer heightened sensitivity, specificity, and efficiency in detecting cancer-related mutations and genetic changes. Liquid biopsy tests involve diagnostic procedures enabling oncologists to assess circulating cell-free DNA released by tumor cells, facilitating personalized and targeted therapy strategies. For instance, in May 2023, Laboratory Corporation of America Holdings (Labcorp), a US-based life sciences company, introduced Labcorp Plasma Focus, a new liquid biopsy test tailored for patients with advanced or metastatic solid tumors. This test evaluates circulating cell-free DNA (cfDNA) from tumor cells through a standard blood draw, ensuring minimal invasiveness and rapid results. It enhances access to precision oncology by identifying clinically actionable biomarkers across various common cancers such as non-small cell lung, colorectal, breast, esophageal, gastroesophageal junction, gastric cancers, and melanoma.

In February 2022, Laboratory Corporation of America Holdings (LabCorp), a US-based clinical healthcare company, acquired Personal Genome Diagnostics Inc. for an undisclosed sum. This acquisition positions LabCorp to advance its existing liquid biopsy capabilities and broaden its array of state-of-the-art next-generation sequencing (NGS)-based genomic profiling tools for cancer, positioning it at the forefront of improving patient outcomes. Personal Genome Diagnostics Inc. specializes in precision oncology diagnostics, including cell-free DNA testing technology.

Major companies operating in the cell free DNA (CFDNA) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Bio-Techne Corporation, Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Invitae Corporation, Foundation Medicine Inc., Guardant Health Inc., Integrated DNA Technologies Inc., Caris Life Sciences Inc., Twist Bioscience Corporation, Adaptive Biotechnologies Corporation, Biodesix Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems Inc., Circulogene Theranostics LLC

North America was the largest region in the cell-free DNA (CFDNA) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell free DNA (CFDNA)) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell free DNA (CFDNA) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell-free DNA (cfDNA) testing market consists of revenue entities earned by providing services such as liquid biopsy for cancer detection and monitoring, transplant rejection monitoring, and non-invasive prenatal testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-free DNA (cfDNA) testing market also includes sales of products such as digital PCR systems, automated nucleic acid extraction systems, real-time PCR instruments, and library preparation systems for NGS. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Free DNA (cfDNA) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell free dna (cfdna) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell free dna (cfdna) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell free dna (cfdna) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Donor-Derived Cell-Free DNA; Circulating Cell-Free Tumor DNA; Cell-Free Fetal DNA
2) By Platforms: Next Generation Sequencing (NGS); rPCR And Multiplexed PCR; qPCR And dPCR; Other platforms
3) By Application: Oncology; Non-Invasive Prenatal Test (NIPT); Gynecology; Transplantation; Other Applications
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18308

1. Executive Summary

2. Cell-Free DNA (cfDNA) Testing Market Characteristics

3. Cell-Free DNA (cfDNA) Testing Market Trends And Strategies

4. Cell-Free DNA (cfDNA) Testing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Cell-Free DNA (cfDNA) Testing Market Size and Growth

5.1. Global Cell-Free DNA (cfDNA) Testing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Cell-Free DNA (cfDNA) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cell-Free DNA (cfDNA) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell-Free DNA (cfDNA) Testing Market Segmentation

6.1. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Donor-Derived Cell-Free DNA
Circulating Cell-Free Tumor DNA
Cell-Free Fetal DNA
6.2. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Next Generation Sequencing (NGS)
rPCR And Multiplexed PCR
qPCR And dPCR
Other platforms
6.3. Global Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oncology
Non-Invasive Prenatal Test (NIPT)
Gynecology
Transplantation
Other Applications

7. Cell-Free DNA (cfDNA) Testing Market Regional And Country Analysis

7.1. Global Cell-Free DNA (cfDNA) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cell-Free DNA (cfDNA) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market

8.1. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell-Free DNA (cfDNA) Testing Market

9.1. China Cell-Free DNA (cfDNA) Testing Market Overview
9.2. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell-Free DNA (cfDNA) Testing Market

10.1. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell-Free DNA (cfDNA) Testing Market

11.1. Japan Cell-Free DNA (cfDNA) Testing Market Overview
11.2. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell-Free DNA (cfDNA) Testing Market

12.1. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell-Free DNA (cfDNA) Testing Market

13.1. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell-Free DNA (cfDNA) Testing Market

14.1. South Korea Cell-Free DNA (cfDNA) Testing Market Overview
14.2. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell-Free DNA (cfDNA) Testing Market

15.1. Western Europe Cell-Free DNA (cfDNA) Testing Market Overview
15.2. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell-Free DNA (cfDNA) Testing Market

16.1. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell-Free DNA (cfDNA) Testing Market

17.1. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell-Free DNA (cfDNA) Testing Market

18.1. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell-Free DNA (cfDNA) Testing Market

19.1. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell-Free DNA (cfDNA) Testing Market

20.1. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell-Free DNA (cfDNA) Testing Market

21.1. Eastern Europe Cell-Free DNA (cfDNA) Testing Market Overview
21.2. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell-Free DNA (cfDNA) Testing Market

22.1. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell-Free DNA (cfDNA) Testing Market

23.1. North America Cell-Free DNA (cfDNA) Testing Market Overview
23.2. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell-Free DNA (cfDNA) Testing Market

24.1. USA Cell-Free DNA (cfDNA) Testing Market Overview
24.2. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell-Free DNA (cfDNA) Testing Market

25.1. Canada Cell-Free DNA (cfDNA) Testing Market Overview
25.2. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell-Free DNA (cfDNA) Testing Market

26.1. South America Cell-Free DNA (cfDNA) Testing Market Overview
26.2. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell-Free DNA (cfDNA) Testing Market

27.1. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell-Free DNA (cfDNA) Testing Market

28.1. Middle East Cell-Free DNA (cfDNA) Testing Market Overview
28.2. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell-Free DNA (cfDNA) Testing Market

29.1. Africa Cell-Free DNA (cfDNA) Testing Market Overview
29.2. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Platforms, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cell-Free DNA (cfDNA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell-Free DNA (cfDNA) Testing Market Competitive Landscape And Company Profiles

30.1. Cell-Free DNA (cfDNA) Testing Market Competitive Landscape
30.2. Cell-Free DNA (cfDNA) Testing Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Thermo Fisher Scientific Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Laboratory Corporation of America Holdings
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Quest Diagnostics Incorporated
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Agilent Technologies Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Cell-Free DNA (cfDNA) Testing Market Other Major And Innovative Companies

31.1. Illumina Inc.
31.2. Qiagen N.V.
31.3. Exact Sciences Corporation
31.4. Bio-Techne Corporation
31.5. Natera Inc.
31.6. Myriad Genetics Inc.
31.7. NeoGenomics Laboratories Inc.
31.8. Invitae Corporation
31.9. Foundation Medicine Inc.
31.10. Guardant Health Inc.
31.11. Integrated DNA Technologies Inc.
31.12. Caris Life Sciences Inc.
31.13. Twist Bioscience Corporation
31.14. Adaptive Biotechnologies Corporation
31.15. Biodesix Inc.

32. Global Cell-Free DNA (cfDNA) Testing Market Competitive Benchmarking

33. Global Cell-Free DNA (cfDNA) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Testing Market

35. Cell-Free DNA (cfDNA) Testing Market Future Outlook and Potential Analysis

35.1 Cell-Free DNA (cfDNA) Testing Market In 2028 - Countries Offering Most New Opportunities
35.2 Cell-Free DNA (cfDNA) Testing Market In 2028 - Segments Offering Most New Opportunities
35.3 Cell-Free DNA (cfDNA) Testing Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer